FDA Wants To Restart Domestic On-Site Inspections On July 20 – But There Are Caveats
Agency devises COVID-19 Advisory Rating System to help it determine whether to send investigators to manufacturing facilities
US FDA commissioner Stephen Hahn said on 10 July that the agency has a plan to send investigators back into the field in 10 days. Whether or not a company is inspected, however, will depend on local COVID-19 conditions.
